医学
脂肪肝
肝硬化
脂肪性肝炎
流行病学
疾病
肝活检
糖尿病
脂肪变性
代谢综合征
肝病学
重症监护医学
内科学
肥胖
活检
内分泌学
作者
Yasser Fouad,Mohamed Alboraie,Gamal Shiha
标识
DOI:10.1007/s12072-024-10704-3
摘要
Abstract The most common chronic liver illness worldwide is metabolic dysfunction linked to fatty liver disease (MAFLD), which is poorly understood by doctors and patients. Many people with this disease develop steatohepatitis, cirrhosis and its consequences, as well as extrahepatic manifestations; these conditions are particularly common if they are linked to diabetes mellitus or obesity. A breakthrough with numerous benefits is the switch from NAFLD to MAFLD in terms of terminology and methodology. The diagnosis of MAFLD is based on affirmative criteria; unlike NAFLD, it is no longer based on exclusion. The diagnosis of MAFLD and the evaluation of steatosis and fibrosis is achieved using liver biopsy and non-invasive laboratory or radiographic techniques. We briefly address the most recent developments in MAFLD epidemiology and diagnosis.
科研通智能强力驱动
Strongly Powered by AbleSci AI